US 12,440,589 B2
Sterilisation assembly
Peter Fitzgerald, Crumlin (GB); David Sloan, Crumlin (GB); Martin Reid, Crumlin (GB); and Stuart Jackson, Crumlin (GB)
Assigned to RANDOX LABORATORIES LTD, Crumlin (GB)
Appl. No. 17/602,831
Filed by RANDOX LABORATORIES LTD, Crumlin (GB)
PCT Filed Apr. 9, 2020, PCT No. PCT/GB2020/050931
§ 371(c)(1), (2) Date Oct. 11, 2021,
PCT Pub. No. WO2020/208364, PCT Pub. Date Oct. 15, 2020.
Claims priority of application No. 1905196 (GB), filed on Apr. 12, 2019.
Prior Publication US 2022/0152244 A1, May 19, 2022
Int. Cl. G01N 35/00 (2006.01); A61L 2/10 (2006.01)
CPC A61L 2/10 (2013.01) [G01N 35/0099 (2013.01); A61L 2202/11 (2013.01); G01N 2035/00326 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A sterilisation assembly for a molecular diagnostic assay analyser, the sterilisation assembly comprising:
an enclosure having a passage therethrough, the passage to allow an assay sample set to pass through the enclosure, the enclosure defining a barrier to restrict fluid communication across the enclosure to communication through the passage; and
a decontaminator located within the passage, the decontaminator to sterilise contamination in the passage;
a moveable stage to removably mount at least one sample;
wherein the moveable stage is to move along a path through the passage, the decontaminator being attached to the moveable stage.